Education
About Us
Working with TipRanks
Follow Us
Fortrea Holdings Inc. (FTRE)
NASDAQ:FTRE
FTRE Stock Chart & Stats
$9.45
-$0.82(-4.27%)
At close: 4:00 PM EST
$9.45
-$0.82(-4.27%)
Day’s Range― - ―
52-Week Range$3.97 - $25.28
Previous CloseN/A
Volume188.47K
Average Volume (3M)1.37M
Market Cap
$858.06M
Enterprise Value$1.61B
Total Cash (Recent Filing)$81.20M
Total Debt (Recent Filing)$1.24B
Price to Earnings (P/E)―
Beta1.60
Next Earnings
Nov 05, 2025EPS Estimate
0.16Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.19
Shares Outstanding90,800,000
10 Day Avg. Volume1,008,218
30 Day Avg. Volume1,374,205
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap1.87
Enterprise Value/Revenue0.59
Enterprise Value/Gross Profit3.09
Enterprise Value/Ebitda-1.87
Forecast
1Y Price Target
$9.79Price Target Upside3.60% Upside
Rating ConsensusHold
Number of Analyst Covering9
Bulls Say, Bears Say
Bulls Say
Cost SavingsThe company continues to make progress with its transformation efforts, achieving one-third of its $90 million-$100 million net savings target for 2025 in the first half of the year.
Financial GuidanceRevenue guidance has been increased to a range of $2.6B-$2.7B.
Revenue PerformanceRevenue of $710 million significantly bested the estimate of $625 million.
Bears Say
Market ShareThe company could continue to lose share because of execution issues and spin-related disruptions.
New Business AwardsNet new business awards of $561 million were significantly below the estimate of $719 million.
Project DelaysManagement noted delays in the start-up of biotech projects and relatively flat clinical development revenue year-over-year.
Fortrea Holdings Inc. News
FTRE FAQ
What was Fortrea Holdings Inc.’s price range in the past 12 months?
Fortrea Holdings Inc. lowest stock price was $3.97 and its highest was $25.28 in the past 12 months.
What is Fortrea Holdings Inc.’s market cap?
Fortrea Holdings Inc.’s market cap is $858.06M.
When is Fortrea Holdings Inc.’s upcoming earnings report date?
Fortrea Holdings Inc.’s upcoming earnings report date is Nov 05, 2025 which is in 15 days.
How were Fortrea Holdings Inc.’s earnings last quarter?
Fortrea Holdings Inc. released its earnings results on Aug 06, 2025. The company reported $0.19 earnings per share for the quarter, beating the consensus estimate of $0.076 by $0.114.
Is Fortrea Holdings Inc. overvalued?
According to Wall Street analysts Fortrea Holdings Inc.’s price is currently Undervalued.
Does Fortrea Holdings Inc. pay dividends?
Fortrea Holdings Inc. does not currently pay dividends.
What is Fortrea Holdings Inc.’s EPS estimate?
Fortrea Holdings Inc.’s EPS estimate is 0.16.
How many shares outstanding does Fortrea Holdings Inc. have?
Fortrea Holdings Inc. has 90,800,000 shares outstanding.
What happened to Fortrea Holdings Inc.’s price movement after its last earnings report?
Fortrea Holdings Inc. reported an EPS of $0.19 in its last earnings report, beating expectations of $0.076. Following the earnings report the stock price went up 0.305%.
Which hedge fund is a major shareholder of Fortrea Holdings Inc.?
Currently, no hedge funds are holding shares in FTRE
Fortrea Holdings Inc. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$9.79 (3.60% Upside)
$9.79 (3.60% Upside)
Blogger Sentiment
Bullish
FTRE Sentiment 100%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Decreased
By 2.6M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $507.2K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 4.1%
Last 30 Days ▲ 0.1%
Last 30 Days ▲ 0.1%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-51.28%
12-Months-Change
Fundamentals
Return on Equity
-100.49%
Trailing 12-Months
Asset Growth
-20.48%
Trailing 12-Months
Company Description
Fortrea Holdings Inc.
Fortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. It operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions to customers that streamline complex randomization and optimize the trial drug supply process. The company offers delivery models that include full service, functional service provider, and hybrid service structures. It also offers phase I-IV clinical trial management, differentiated technology enabled trial solutions, and post approval services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. was incorporated in 2023 and is based in Durham, North Carolina.
FTRE Company Deck
FTRE Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call for Fortrea's second quarter of 2025 highlighted strong revenue growth and positive cash flow, driven by the clinical pharmacology segment and operational efficiencies. However, these positives were offset by a significant net loss due to goodwill impairment and challenges in securing new business from biotech customers amid a leadership transition.View all FTRE earnings summariesFTRE Stock 12 Month Forecast
Average Price Target
$9.79
▲(3.60% Upside)
Technical Analysis
Nektar Therapeutics
―
Fulcrum Therapeutics
―
Compass Therapeutics
―
Erasca
―
Aura Biosciences Inc
―
Ownership Overview
0.53% Insiders
19.64% Mutual Funds
0.49% Other Institutional Investors
46.63% Public Companies and
Individual Investors